Reply to Xiao Li, Zicheng Xu, and Feng Qi's Letter to the Editor re: Soumyajit Roy, Yilun Sun, Scott C. Morgan, et al. Effect of Prior Local Therapy on Response to First-line Androgen Receptor Axis Targeted Therapy in Metastatic Castrate-resistant Prostate Cancer: A Secondary Analysis of the COU-AA-302 Trial. Eur Urol 2023;83:571-9.

作者信息

Roy Soumyajit, Sun Yilun, Morgan Scott, Malone Shawn

机构信息

Department of Radiation Oncology, Rush University Medical Center, Chicago, IL, USA.

Department of Population and Quantitative Health Sciences, School of Medicine, Case Western Reserve University, Cleveland, OH, USA.

出版信息

Eur Urol. 2024 Jan;85(1):e12-e13. doi: 10.1016/j.eururo.2023.08.005. Epub 2023 Aug 16.

DOI:10.1016/j.eururo.2023.08.005

PMID:37596192

Abstract

摘要

相似文献

Reply to Xiao Li, Zicheng Xu, and Feng Qi's Letter to the Editor re: Soumyajit Roy, Yilun Sun, Scott C. Morgan, et al. Effect of Prior Local Therapy on Response to First-line Androgen Receptor Axis Targeted Therapy in Metastatic Castrate-resistant Prostate Cancer: A Secondary Analysis of the COU-AA-302 Trial. Eur Urol 2023;83:571-9.

Eur Urol. 2024 Jan;85(1):e12-e13. doi: 10.1016/j.eururo.2023.08.005. Epub 2023 Aug 16.

Re: Soumyajit Roy, Yilun Sun, Scott C. Morgan, et al. Effect of Prior Local Therapy on Response to First-line Androgen Receptor Axis Targeted Therapy in Metastatic Castrate-resistant Prostate Cancer: A Secondary Analysis of the COU-AA-302 Trial. Eur Urol 2023;83:571-9.

Eur Urol. 2024 Jan;85(1):e14. doi: 10.1016/j.eururo.2023.06.034. Epub 2023 Aug 16.

Reply to Feng Qi, Zicheng Xu, and Qing Zou's Letter to the Editor re: Andrea Loehr, Arif Hussain, Akash Patnaik, et al. Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-resistant Prostate Cancer After Treatment with Rucaparib. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.09.010.回复冯琦、徐子成和邹清致编辑的信，信的内容关于：安德里亚·勒尔、阿里夫·侯赛因、阿卡什·帕奈克等人。鲁卡帕尼治疗后转移性去势抵抗性前列腺癌患者中BRCA回复突变的出现。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2022.09.010 。

Eur Urol. 2023 Mar;83(3):e78. doi: 10.1016/j.eururo.2022.12.023. Epub 2023 Jan 7.

Reply to Yongfeng Lao, Yanan Wang, and Zhilong Dong's Letter to the Editor re: Amar U. Kishan, Xiaoyan Wang, Yilun Sun, et al. High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP Consortium. Eur Urol. 2022;82:106-114.回复劳永丰、王亚楠和董志龙致编辑的信，信的内容是关于阿马尔·U·基尚、王小燕、孙逸伦等人的研究：《高剂量放疗或雄激素剥夺疗法（HEAT）作为局限性前列腺癌治疗强化手段：来自MARCAP联盟的个体患者数据网络荟萃分析》。《欧洲泌尿外科杂志》。2022年；82卷：106 - 114页。

Eur Urol. 2022 Sep;82(3):e82-e83. doi: 10.1016/j.eururo.2022.05.033. Epub 2022 Jun 7.

Reply to Adam G. Sowalsky, Stephen R. Plymate, Michael C. Haffner, Johann S. de Bono, and Adam Sharp's Letter to the Editor re: Heng Li, Yucong Zhang, Dong Li, et al. Androgen Receptor Splice Variant 7 Predicts Shorter Response in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Deprivation Therapy. Eur Urol 2021;79:879-86: AR-V7 is Rare in Hormone-sensitive Prostate Cancer.对亚当·G·索瓦尔斯基、斯蒂芬·R·普利梅特、迈克尔·C·哈夫纳、约翰·S·德博诺和亚当·夏普致编辑的信的回复，信的主题为：李恒、张玉聪、李东等人。雄激素受体剪接变体7预测接受雄激素剥夺治疗的转移性激素敏感性前列腺癌患者的反应持续时间较短。《欧洲泌尿外科杂志》2021年；79:879 - 86：AR-V7在激素敏感性前列腺癌中罕见

Eur Urol. 2022 Nov;82(5):e137-e138. doi: 10.1016/j.eururo.2022.08.013. Epub 2022 Sep 7.

Reply to Feng Qi's Letter to the Editor re: Niklas Klümper, Viktor Grünwald, Arndt Hartmann, et al. The Role of Microsatellite Instability/DNA Mismatch Repair Deficiency and Tumor Mutational Burden as Biomarkers in Predicting Response to Immunotherapy in Castration-resistant Prostate Cancer. Eur Urol. 2024;86:388-390.

Eur Urol. 2025 Jan;87(1):e17-e18. doi: 10.1016/j.eururo.2024.09.019. Epub 2024 Sep 23.

Reply to Ashwin Shinde, Richard Li, Arya Amini, and Scott Glaser's Letter to the Editor re: Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410-8: Future Steps for Definitive Therapy in Metastatic Prostate Cancer: Lessons from the HORRAD TrialUntil Randomised Controlled Trials Prove Different, Treat the Patient, Not His Imaging Results.回复阿什温·辛德、理查德·李、阿莉亚·阿米尼和斯科特·格拉泽给编辑的信，信的内容涉及：利塞尔洛特·M·S·博埃夫、马腾·C·C·M·胡尔肖夫、安德烈·N·维斯等人。在一项前瞻性随机临床试验中，单纯雄激素剥夺疗法与雄激素剥夺疗法联合前列腺同步放射疗法对原发性骨转移性前列腺癌患者生存的影响：来自HORRAD试验的数据。《欧洲泌尿外科杂志》2019年；75卷：410 - 418页：转移性前列腺癌确定性治疗的未来步骤：来自HORRAD试验的经验教训直到随机对照试验证明情况不同之前，治疗患者，而非其影像学结果。

Eur Urol. 2019 Mar;75(3):e71-e72. doi: 10.1016/j.eururo.2018.11.007. Epub 2018 Nov 22.

Effect of Prior Local Therapy on Response to First-line Androgen Receptor Axis Targeted Therapy in Metastatic Castrate-resistant Prostate Cancer: A Secondary Analysis of the COU-AA-302 Trial.局部治疗在先对转移性去势抵抗性前列腺癌一线抗雄激素受体轴靶向治疗反应的影响：COU-AA-302 试验的二次分析。

Eur Urol. 2023 Jun;83(6):571-579. doi: 10.1016/j.eururo.2023.02.017. Epub 2023 Mar 7.

Reply to Fabiana Gregucci and Alba Fiorentino's Letter to the Editor re: Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomized Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410-8.

Eur Urol. 2019 May;75(5):e131-e132. doi: 10.1016/j.eururo.2018.12.024. Epub 2019 Jan 4.

Re: Amar U. Kishan, Xiaoyan Wang, Yilun Sun, et al. High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP Consortium. Eur Urol. 2022;82:106-14.

Eur Urol. 2022 Sep;82(3):e80-e81. doi: 10.1016/j.eururo.2022.05.034. Epub 2022 Jun 7.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

作者信息

机构信息

出版信息

相似文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献